Poland declines to take or pay for more COVID-19 vaccines for now | Inquirer News

Poland declines to take or pay for more COVID-19 vaccines for now

/ 08:02 PM April 19, 2022

Poland declines to take or pay for more COVID-19 vaccines for now

FILE PHOTO: A doctor prepares the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at the University Hospital in Bialystok, Poland January 4, 2021. Agnieszka Sadowska/Agencja Gazeta via REUTERS

WARSAW — Poland will not take or pay for more doses of COVID-19 vaccine under the European Union’s (EU) supply contract, its health minister said Tuesday, setting the stage for a legal battle with manufacturers.

Poland, along with other EU members, has been receiving COVID-19 vaccines during the coronavirus pandemic under supply contracts agreed between the European Commission and vaccine makers such as BioNTech SE and Pfizer or Moderna.

Article continues after this advertisement

Poland’s biggest supplier is Pfizer. However, the country has seen lower vaccine uptake than most of the European Union and has surplus vaccine stock, part of which it has sold or donated to other countries.

FEATURED STORIES

“At the end of last week, we used the force majeure clause and informed both the European Commission and the main vaccine producer that we are refusing to take these vaccines at the moment and we are also refusing to pay,” health minister Adam Niedzielski told private broadcaster TVN24.

“Indeed, the consequence of this will be a legal conflict, which is already taking place,” he said.

Article continues after this advertisement

Poland cannot directly terminate the contract for the supply of vaccines as the parties to the contracts are the European Commission and manufacturers, he said.

Article continues after this advertisement

The value of the contract for vaccine supplies to Poland up to the end of 2023 with one producer alone was worth over 6 billion zlotys ($1.4 billion), with over 2 billion zlotys of that for supply in 2022.

Article continues after this advertisement

Pfizer said its agreement over the supply of its COVID-19 vaccine to European Union member states was with the EU Commission.

“Our discussions with Governments and the details of vaccine deliveries are confidential,” it added.

Article continues after this advertisement

Pfizer’s partner BioNTech only said that Pfizer was in charge of the commercial relationship with Poland.

Poland, a country of around 38 million people, has reported 5,983,864 cases of the coronavirus and 115,809 deaths.

READ: In vaccine-shy Poland, COVID deaths top 100,000

European Commission health spokesman Stefan de Keersmaecker told a news conference on Tuesday that member states were bound by contractual obligations, but that it understood Poland’s “difficult position.”

“We continue to facilitate discussion between the Polish government and the company in order to find a pragmatic solution to this specific situation the country is confronted with,” he said.

In Poland, 59% of the population has been vaccinated with two doses and 31% has received a booster shot. This is well below the EU average of 72.5% and nearly 53%, respectively.

($1 = 4.2868 zlotys)

RELATED STORY

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Poland has entered a fifth wave of COVID, says minister

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Health, Pfizer, Poland, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.